AstraZeneca Meet the Management Event at ASCO 2025
Monday 2 June 2025, 7 PM CST | 8 PM EST | 1 AM BST | 2 AM CEST
Key facts
Epidemiology
Contacts
Latest aide memoire
Upcoming events
Conference, Goldman Sachs Global Healthcare Conference, Miami [Management]
Conference, Capital World 'Healthcare Summit’, Cambridge [Management]
Conference, J.P. Morgan European Healthcare Forum, London [Management]
Annual Reports
Archive
Investor enquiries
Main Contacts
Andy Barnett
Head of Investor Relations
Christer Gruvris
BioPharmaceuticals
(Cardiovascular, Renal and Metabolism),
Finance & Fixed Income
Lauren Swales
Rare Disease
Isabel Gibson
Oncology
Philip Sparks
BioPharmaceuticals
(Vaccines & Immune Therapies)
Rachel Korolyshun
Rare Disease,
Environment, Social and Governance
Elizabeth Walton
BioPharmaceuticals
(Respiratory & Immunology), Environment, Social and Governance
-
Shareholder information
Please find relevant shareholder information and shareholder tools on this page
-
Shareholder FAQs
Answers to frequently asked shareholder questions
-
Governance
We apply the principles of good corporate governance in the UK Corporate Governance Code and related guidance
